tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Insufficiency D000309 3 associated lipids
Akinetic Mutism D000405 1 associated lipids
Albuminuria D000419 18 associated lipids
Alopecia D000505 14 associated lipids
Alopecia Areata D000506 6 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amenorrhea D000568 4 associated lipids
Amputation, Traumatic D000673 2 associated lipids
Anemia D000740 21 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Refractory D000753 3 associated lipids
Anemia, Refractory, with Excess of Blasts D000754 2 associated lipids
Aneurysm, Dissecting D000784 2 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Angioedema D000799 6 associated lipids
Anus Diseases D001004 3 associated lipids
Apraxias D001072 1 associated lipids
Arm Injuries D001134 1 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Ascites D001201 25 associated lipids
Ataxia D001259 20 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Autonomic Nervous System Diseases D001342 4 associated lipids
Bacterial Infections D001424 21 associated lipids
Balanitis D001446 4 associated lipids
Beckwith-Wiedemann Syndrome D001506 1 associated lipids
Behcet Syndrome D001528 7 associated lipids
Biliary Fistula D001658 13 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Blepharitis D001762 4 associated lipids
Blindness D001766 6 associated lipids
Body Weight D001835 333 associated lipids
Bone Diseases D001847 4 associated lipids
Bradycardia D001919 13 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Edema D001929 20 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
Cardiomyopathy, Restrictive D002313 1 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Carpal Tunnel Syndrome D002349 3 associated lipids
Catalepsy D002375 30 associated lipids
Cataract D002386 34 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Myoclonic Cerebellar Dyssynergia D002527 1 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Uterine Cervical Dysplasia D002578 2 associated lipids
Cheilitis D002613 2 associated lipids
Cholelithiasis D002769 16 associated lipids
Cholestasis D002779 23 associated lipids
Choline Deficiency D002796 16 associated lipids
Hemophilia B D002836 3 associated lipids
Chronic Disease D002908 7 associated lipids
Cicatrix D002921 9 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Collagen Diseases D003095 2 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Confusion D003221 4 associated lipids
Connective Tissue Diseases D003240 2 associated lipids
Corneal Diseases D003316 13 associated lipids
Cough D003371 19 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Crohn Disease D003424 12 associated lipids
Cryptococcosis D003453 3 associated lipids
Cutis Laxa D003483 1 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cystitis D003556 23 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Hearing Loss, Sudden D003639 1 associated lipids
Deglutition Disorders D003680 2 associated lipids
Dehydration D003681 11 associated lipids
Demyelinating Diseases D003711 15 associated lipids
Dental Enamel Hypoplasia D003744 2 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Dermatitis D003872 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Grinyó JM and Petruzzelli S Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations. 2014 Expert Rev Clin Immunol pmid:25407098
Hattori Y et al. Influence of cytochrome P450 3A5 polymorphisms on viral infection incidence in kidney transplant patients treated with tacrolimus. 2014 Transplant. Proc. pmid:24656015
Uchida J et al. Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients. 2014 Transplant. Proc. pmid:24656005
Zaltzman JS et al. A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers. 2014 Transpl. Int. pmid:25160518
Misra DP et al. Pulmonary co-infection with Nocardia and Aspergillus in a patient with adult-onset Still's disease receiving steroids and tacrolimus. 2014 BMJ Case Rep pmid:25398925
Weng LC et al. Association between use of FK506 and prevalence of post-transplantation diabetes mellitus in kidney transplant patients. 2014 Transplant. Proc. pmid:24656004
Takahashi K et al. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan. 2014 Transplant. Proc. pmid:24655975
Wu MJ et al. Reduced variability of tacrolimus trough level in once-daily tacrolimus-based Taiwanese kidney transplant recipients with high-expressive genotype of cytochrome P450 3A5. 2014 Transplant. Proc. pmid:24655974
Cusinato DA et al. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients. 2014 Br J Clin Pharmacol pmid:24528196
Gérard C et al. Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach. 2014 AAPS J pmid:24526611
Leung EK et al. Clinical evaluation of the QMS® Tacrolimus immunoassay. 2014 Clin. Chim. Acta pmid:24518359
McCormack PL Extended-release tacrolimus: a review of its use in de novo kidney transplantation. 2014 Drugs pmid:25352392
Qi R et al. FK506 inhibits the mice glomerular mesangial cells proliferation by affecting the transforming growth factor-β and Smads signal pathways. 2014 Ren Fail pmid:24512120
Mocchegiani F et al. Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis. 2014 Ann. Transplant. pmid:25347718
Klawitter J et al. Mycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolism. 2014 PLoS ONE pmid:24497939
Filler G Finding the optimal therapeutic window for tacrolimus. 2014 Pediatr Transplant pmid:25345999
Okada K et al. [Single institution experience of HLA-haploidentical hematopoietic stem cell transplantation for children: current problems and perspective]. 2014 Rinsho Ketsueki pmid:24492043
Thölking G et al. The tacrolimus metabolism rate influences renal function after kidney transplantation. 2014 PLoS ONE pmid:25340655
Méndez A et al. Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation. 2014 Transplantation pmid:24492423
Moss MC et al. Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? 2014 Transplantation pmid:24492429
Lipson EJ et al. Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma. 2014 J. Clin. Oncol. pmid:24493726
Hinchliffe E et al. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots. 2014 Ann. Clin. Biochem. pmid:23939194
Pulsipher MA et al. The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. 2014 Blood pmid:24497539
Torres IB et al. The Interplay between inflammation and fibrosis in kidney transplantation. 2014 Biomed Res Int pmid:24991565
Isoda K et al. The proton pump inhibitor lansoprazole, but not rabeprazole, the increased blood concentrations of calcineurin inhibitors in Japanese patients with connective tissue diseases. 2014 Intern. Med. pmid:24990333
Wada A et al. Ribosome display and photo-cross-linking techniques for in vitro identification of target proteins of bioactive small molecules. 2014 Anal. Chem. pmid:24380432
Buendia JA et al. Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis. 2014 Ther Drug Monit pmid:24378577
Eid L et al. Late acute rejection: incidence, risk factors, and effect on graft survival and function. 2014 Pediatr Transplant pmid:24372967
Peng ZG and Tian J Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients. 2014 Clin Transpl pmid:26281147
Filler G et al. Similar MPA exposure on modified release and regular tacrolimus. 2014 Ther Drug Monit pmid:24365986
Jain A et al. Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. 2014 Transplantation pmid:25285953
Gounden V and Soldin SJ Tacrolimus measurement: building a better immunoassay. 2014 Clin. Chem. pmid:24415738
Basu B Ofatumumab for rituximab-resistant nephrotic syndrome. 2014 N. Engl. J. Med. pmid:24670185
Takeuchi T et al. Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis. 2014 Mod Rheumatol pmid:24261753
Fukushima A et al. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. 2014 Br J Ophthalmol pmid:24695688
Cho A et al. Calcineurin signaling regulates neural induction through antagonizing the BMP pathway. 2014 Neuron pmid:24698271
Czubkowski P et al. Cardiovascular risk factors after conversion from cyclosporine to tacrolimus in children after liver transplantation. 2014 Ann. Transplant. pmid:25409773
Guitard J et al. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. 2014 Clin. Nephrol. pmid:24040781
Protic M et al. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients. 2014 J Crohns Colitis pmid:24908178
Hayashi K et al. Delayed false elevation of circulating tacrolimus concentrations after cord blood transplantation in a patient with myelodysplastic syndrome. 2014 Intern. Med. pmid:25400189
Sugiyama K et al. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor. 2014 Exp Clin Transplant pmid:24907718
Lankarani KB et al. New onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose. 2014 Exp Clin Transplant pmid:23902591
Spagnoletti G et al. Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up. 2014 Transplant. Proc. pmid:25242756
Schellekens J et al. The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity? 2014 Transpl. Immunol. pmid:25240735
Liu FL et al. FKBP12 regulates the localization and processing of amyloid precursor protein in human cell lines. 2014 J. Biosci. pmid:24499793
Parks AC et al. Long-term clearance of linear porokeratosis with tacrolimus, 0.1%, ointment. 2014 JAMA Dermatol pmid:24553841
Xu C et al. Tacrolimus reversibly reduces insulin secretion, induces insulin resistance, and causes islet cell damage in rats. 2014 Int J Clin Pharmacol Ther pmid:24755137
Ichinose K et al. [Rare case of systemic lupus erythematosus with encapsulating peritoneal sclerosis during hemodialysis]. 2014 Nihon Jinzo Gakkai Shi pmid:24730352
Schmid S et al. Volatility of serum creatinine relative to tacrolimus levels predicts kidney transplant rejection. 2014 Ann. Transplant. pmid:25123847
Caraveo G et al. Calcineurin determines toxic versus beneficial responses to α-synuclein. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25122673
Gajanayake T et al. A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft. 2014 Sci Transl Med pmid:25122638
Thorat A et al. Effects of converting tacrolimus formulation from twice-daily to once-daily in liver transplantation recipients. 2014 Biomed Res Int pmid:25121091
Griffith RD et al. Cells to surgery quiz: September 2014. 2014 J. Invest. Dermatol. pmid:25120152
García-García B et al. Frosch' surface microscopy score for the assessment of steroid-induced atrophy. 2014 Arch. Dermatol. Res. pmid:24402286
Gionchetti P and Rizzello F IBD. Sequential rescue therapy in steroid-refractory ulcerative colitis. 2014 Nat Rev Gastroenterol Hepatol pmid:25023033
Van der Hauwaert C et al. Expression profiles of genes involved in xenobiotic metabolism and disposition in human renal tissues and renal cell models. 2014 Toxicol. Appl. Pharmacol. pmid:25036895
Helenius-Hietala J et al. Oral mucosal health in liver transplant recipients and controls. 2014 Liver Transpl. pmid:24142471
Tsuchida T et al. The development of humanized liver with Rag1 knockout rats. 2014 Transplant. Proc. pmid:24815157
Farkas K et al. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis. 2014 Expert Rev Gastroenterol Hepatol pmid:24738535
Hamilton BK and Kalaycio M Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxis. 2014 Biol. Blood Marrow Transplant. pmid:25065905
Shimizu M et al. Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus. 2014 Rheumatology (Oxford) pmid:25065006
Dai YJ et al. Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris. 2014 Asian Pac J Trop Med pmid:25063291
Garriga-Companys S and Labrador-Horrillo M [Chronic spontaneous urticaria]. 2014 Med Clin (Barc) pmid:24120109
Kurzawski M et al. Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients. 2014 Pharmacogenet. Genomics pmid:24921414
Marits P et al. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay. 2014 Clin. Immunol. pmid:24909732
Uesugi M et al. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation. 2014 Pharmacogenet. Genomics pmid:24911663
Di Stasio D et al. Oral lichen planus: a narrative review. 2014 Front Biosci (Elite Ed) pmid:24896212
Levinger E et al. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. 2014 Graefes Arch. Clin. Exp. Ophthalmol. pmid:24696044
Al-Harbi NO et al. Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue. 2014 Biomed Res Int pmid:24987695
Nikitin AV [Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors]. 2014 Antibiot. Khimioter. pmid:25051716
Sun J et al. [A preliminary study on the biological characteristics and function of tolerogenic dendritic cells induced by tacrolimus]. 2014 Zhonghua Xue Ye Xue Za Zhi pmid:24985179
GoriaÄ­nov VA et al. [Effect of tacrolimus on the results of living related kidney donor transplantation]. 2014 Ter. Arkh. pmid:25095659
Carbajal R et al. Case report: boldo (Peumus boldus) and tacrolimus interaction in a renal transplant patient. 2014 Transplant. Proc. pmid:24981811
Saracino A et al. Multidrug-resistance 1 gene single-nucleotide polymorphisms do not influence long-term graft survival after kidney transplantation. 2014 Transplant. Proc. pmid:25242754
Lan X et al. Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. 2014 World J. Gastroenterol. pmid:25232269
Ji SM et al. Retrospective evaluation of the effect of mycophenolate mofetil dosage on survival of kidney grafts based on biopsy results. 2014 Transplant. Proc. pmid:25498056
Zhu H et al. Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo. 2014 Mol Med Rep pmid:24912495
Van Laecke S et al. The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. 2014 Transpl. Int. pmid:24909487
Hosohata K et al. Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients. 2014 Drug Metab. Pharmacokinet. pmid:23955548
Trkulja V et al. Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data. 2014 Ther Drug Monit pmid:24518562
Foroncewicz B et al. Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis. 2014 Ann. Transplant. pmid:25163829
Hayashi T and Harada N Post-translational dual regulation of cytochrome P450 aromatase at the catalytic and protein levels by phosphorylation/dephosphorylation. 2014 FEBS J. pmid:25158681
Savikko J et al. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome. 2014 Transpl. Immunol. pmid:25158212
Kern G et al. Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling. 2014 PLoS ONE pmid:24816588
Lebel MJ et al. Increase in de novo food allergies after pediatric liver transplantation: tacrolimus vs. cyclosporine immunosuppression. 2014 Pediatr Transplant pmid:25156571
Sánchez L et al. Topical tacrolimus for recurrent penile Crohn's disease. 2014 J Crohns Colitis pmid:24815787
Reynolds BC et al. Use of belatacept to maintain adequate early immunosuppression in calcineurin-mediated microangiopathic hemolysis post-renal transplant. 2014 Pediatr Transplant pmid:24815506
Kim YE and Eun SC Effect of FK506 ointment (Protopic) on rat skin allograft model. 2014 Transplant. Proc. pmid:24815165
Lee KM and Eun SC Experimental canine facial transplantation. 2014 Transplant. Proc. pmid:24815162
Wang J and Fan H [Assessment of P70S6 kinase phosphorylation after liver transplantation by phospho-flow cytometry]. 2014 Zhonghua Yi Xue Za Zhi pmid:25623311
Osmola-Mańkowska A et al. Topical tacrolimus vs medium-dose ultraviolet A1 phototherapy in the treatment of atopic dermatitis - a preliminary study in relation to parameters of the epidermal barrier function and high-frequency ultrasonography. 2014 Eur Rev Med Pharmacol Sci pmid:25555886
Ishikawa Y and Bächinger HP A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis. 2014 J. Biol. Chem. pmid:24821723
Upadhyay V et al. Rapid and sensitive UPLC-MS-MS determination of tacrolimus in Wistar rats and human blood. 2014 J Chromatogr Sci pmid:23264321
Hilgers M and Megahed M [Oral lichen planus. Insight into the pathogenesis and therapeutic options]. 2014 Hautarzt pmid:24722910
Shipkova M et al. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay. 2014 Clin. Biochem. pmid:24721684
Lin BW et al. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye. 2014 Invest. Ophthalmol. Vis. Sci. pmid:25491293
Lee SJ et al. Functional interpretation of metabolomics data as a new method for predicting long-term side effects: treatment of atopic dermatitis in infants. 2014 Sci Rep pmid:25491116
Hsiao FY and Hsu WW Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study. 2014 Int Urol Nephrol pmid:24009082
Földes G et al. Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells. 2014 Stem Cells Dev. pmid:24192059
Kharfan-Dabaja M et al. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation. 2014 Cochrane Database Syst Rev pmid:25061777